跳至主要内容
临床试验/NCT01559571
NCT01559571已完成不适用

Study Registry for Severe Retinopathy and Treatment on Visual Outcomes of Premature Neonates

Pediatrix2 个研究点 分布在 1 个国家目标入组 324 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pediatrix
入组人数
324
试验地点
2
主要终点
Identification of visual acuity in subjects who were treated for ROP

研究概览

简要总结

The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 7 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Documentation of informed consent and authorization
  • Inborn and those admitted within 7 days of birth
  • Infant with a diagnosis of stage 2 ROP or higher
  • Site ability to plan close ophthalmological follow-up due to significant and persistent ROP
  • Parents must agree to report outcomes following each ophthalmological visit and overall outcomes for up to five (5) years of age
  • Ability to obtain follow-up data on outcomes if the child is transferred to another facility
  • No known major congenital anomalies

排除标准

  • ROP stage 1 or less
  • Parents unwilling to participate in follow-up
  • Major congenital anomalies

结局指标

主要结局

Identification of visual acuity in subjects who were treated for ROP

时间窗: Five year follow-up

次要结局

  • Recurrence of stage 3+ retinopathy of prematurity in one or both eyes in zone I or posterior zone II Recurrence of stage 3+ retinopathy of prematurity in one or both eyes in zone I or posterior zone II(Five year follow-up)

研究者

发起方
Pediatrix
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验